These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38462016)

  • 1. Delays in Cervical Cancer Treatment Initiation for Patients Living With or Without HIV in Botswana: An Observational Cohort Analysis (2015-2019).
    George J; Tuli S; Patel PP; Monare B; Ramogola-Masire D; Bazzett-Matabele L; Bvochora-Nsingo M; Chiyapo S; Ralefala T; Vuylsteke P; Rendle KA; Grover S
    Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1368-1378. PubMed ID: 38462016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
    Grover S; MacDuffie EC; Wang Q; Bvochora-Nsingo M; Bhatia RK; Balang D; Chiyapo SP; Luckett R; Ramogola-Masire D; Dryden-Peterson SL; Lin LL; Shin SS; Zetola NM
    Cancer; 2019 May; 125(10):1645-1653. PubMed ID: 30801696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
    Meghani K; Puri P; Bazzett-Matabele L; Vuylsteke P; Luckett R; Monare B; Chiyapo S; Ketlametswe R; Ralefala TB; Bvochora-Nsingo M; Zetola N; Ramogola-Masire D; Grover S
    Cancer; 2024 Jul; 130(14):2462-2471. PubMed ID: 38529676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between CD4 Count and Chemoradiation Therapy Outcomes Among Cervical Cancer Patients With HIV.
    Grover S; Mehta P; Wang Q; Bhatia R; Bvochora-Nsingo M; Davey S; Iyengar M; Shah S; Shin SS; Zetola NM
    J Acquir Immune Defic Syndr; 2020 Oct; 85(2):201-208. PubMed ID: 32568769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient perspectives on delays in cervical cancer screening and follow-up care in Botswana: a mixed methods study.
    Rendle KA; Ramogola-Masire D; Monare B; Ogden SN; Toneff HK; Saia CA; Wainwright JV; Friebel-Klingner TM; Bazzett-Matabele L; Bhatia R; Bonner N; Ralefala TB; Vuylsteke P; Luckett R; Grover S
    BMC Womens Health; 2022 May; 22(1):195. PubMed ID: 35643491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
    Grover S; Bvochora-Nsingo M; Yeager A; Chiyapo S; Bhatia R; MacDuffie E; Puri P; Balang D; Ratcliffe S; Narasimhamurthy M; Gwangwava E; Tsietso S; Kayembe MKA; Ramogola-Masire D; Dryden-Peterson S; Mahantshetty U; Viswanathan AN; Zetola NM; Lin LL
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):201-210. PubMed ID: 29619965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical Cancer Treatment Delays and Associated Factors in a Cohort of Women From a Developing Country.
    Ferreira da Silva I; Ferreira da Silva I; Koifman RJ
    J Glob Oncol; 2019 Jan; 5():1-11. PubMed ID: 30694738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
    Grover S; Ning MS; Bale M; Lichter KE; Shah S; Bvochora-Nsingo M; Chiyapo S; Balang D; McGinnis GJ; Ralefala T; Moloi T; Luckett R; Ramogola-Masire D; Robertson ES; Zetola NM
    Int J Gynecol Cancer; 2021 Sep; 31(9):1220-1227. PubMed ID: 34312220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Head and Neck Cancers With or Without Comorbid HIV Infection in Botswana.
    McGinnis GJ; Ning MS; Bvochora-Nsingo M; Chiyapo S; Balang D; Ralefala T; Lin A; Zetola NM; Grover S
    Laryngoscope; 2021 May; 131(5):E1558-E1566. PubMed ID: 33098322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic.
    Matsuo K; Huang Y; Matsuzaki S; Ragab OM; Roman LD; Wright JD
    Gynecol Oncol; 2021 May; 161(2):414-421. PubMed ID: 33771396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.
    DeBoer RJ; Umutoni V; Bazzett-Matabele L; Katznelson E; Nguyen C; Umwizerwa A; Bigirimana JB; Paciorek A; Nsabimana N; Ruhangaza D; Ntasumbumuyange D; Shulman LN; Triedman SA; Shyirambere C
    Gynecol Oncol; 2022 Feb; 164(2):370-378. PubMed ID: 34916066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in time to start of definitive radiation treatment for patients with locally advanced cervical cancer.
    Kotha NV; Williamson CW; Mell LK; Murphy JD; Martinez E; Binder PS; Mayadev JS
    Int J Gynecol Cancer; 2022 May; 32(5):613-618. PubMed ID: 35428688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic Setting.
    Brown CA; Suneja G; Tapela N; Mapes A; Pusoentsi M; Mmalane M; Hodgeman R; Boyer M; Musimar Z; Ramogola-Masire D; Grover S; Nsingo-Bvochora M; Kayembe M; Efstathiou J; Lockman S; Dryden-Peterson S
    Oncologist; 2016 Jun; 21(6):731-8. PubMed ID: 27053501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020.
    Grover S; George J; Tuli S; Lichter K; Bhatia R; Monare B; Chinniah G; Bazzett-Matabele L; Bvochora-Nsingo M; Chiyapo S; Balang D; Ralefala T; Vuylsteke P; Luckett R; Shin S; Zetola N; Ramogola-Masire D
    Gynecol Oncol Rep; 2022 Dec; 44():101094. PubMed ID: 36337265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer treatment initiation and survival: The role of residential proximity to cancer care.
    Hung P; Zahnd WE; Brandt HM; Adams SA; Wang S; Eberth JM
    Gynecol Oncol; 2021 Jan; 160(1):219-226. PubMed ID: 33081985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Factors Associated With Delays in Obtaining Cancer Care in Botswana.
    Bhatia RK; Rayne S; Rate W; Bakwenabatsile L; Monare B; Anakwenze C; Dhillon P; Narasimhamurthy M; Dryden-Peterson S; Grover S
    J Glob Oncol; 2018 Aug; 4():1-13. PubMed ID: 30199305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distance to Multidisciplinary Team Clinic in Gaborone, Botswana, and Stage at Cervical Cancer Presentation for Women Living With and Without HIV.
    Friebel-Klingner TM; Bazzett-Matabele L; Ramogola-Masire D; Monare B; Ralefala TB; Seiphetlheng A; Ramontshonyana G; Vuylsteke P; Mitra N; Wiebe DJ; Rebbeck TR; McCarthy AM; Grover S
    JCO Glob Oncol; 2022 Nov; 8():e2200183. PubMed ID: 36395437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.